Patient and parent involvement is at the heart of Duchenne UK. We believe that patients should be at the heart of drug development. Our Patient Advisory Board (PAB) is made up of parents of children and young adults of different ages, who advise and give feedback on the projects we are considering for funding. 

Alasdair Robertson

Alasdair is chair of the Patient Advisory Board and also the first parent member of our Scientific Advisory Board. His son Felix, aged 4, was diagnosed with Duchenne in December 2014, since when he has wholeheartedly thrown himself in to the race to find a cure, as well as the search for innovative, disease-mitigating treatments.

Alasdair studied at Loughborough University and the University of Cambridge. He has a London based surveying company and lives in Gloucestershire, with his wife Robyn, their two children, Felix and his little sister Lumi, aged 2, and ‘Happy’ the dog.


Rebecca Burnett 

Becky Burnett is mother to Tom, who has Duchenne muscular dystrophy, and Amy. She graduated from Oxford University and worked in London and Hampshire as a lawyer specialising in medical negligence. Shortly after Tom was born in 2007, she and her husband Gary, spent 3 years self-building their dream home - Tom was diagnosed with Duchenne muscular dystrophy a few weeks after they had moved in. 

Tom has taken part in 3 clinical trials at Great Ormond Street Hospital, two for an experimental drug for Duchenne and one for a distraction device used when giving blood. Her experience during this time has left her in no doubt that the patient voice is not being listened to by the drug companies and she believes passionately that it should be the primary consideration at every step of drug research.

Nick Catlin

Nick is the parent of a son, Saul 16, who is living with Duchenne muscular dystrophy. He was the founder member and former CEO for the charity, Action Duchenne. Nick has an honours degree in Chemistry and a PGCE. He established the first patient clinical trial database, the DMD Registry, and is currently a member of its advisory board. He is also a member of the Treat NMD TACT committee for evaluating new treatments and medicines for Duchenne. In 2005 until 2012 he was a member of the MDEX Consortium SAB that supported the first clinical trial for exon skipping using morpholinos with boys living with DMD in the UK. When CEO at Action Duchenne, Nick established and contributed to the first of many Duchenne International research Conferences in the UK and he also set up the APPG for Muscular Dystrophy in the Houses of Parliament. He has recently campaigned with families to win approval for the PTC genetic therapy Translarna with NICE and NHS England.

Fleur Chandler

Fleur is a health economist and has worked in the pharma industry for over 20 years, across Clinical Research and Health Outcomes. Her current role at GSK is Therapeutic Area Head in Global Value Evidence and Outcomes. Her son, Dom (now 10) has DMD.

 

  

Lisa Kuhwald

Lisa is mum to 4 boys, Oscar, Casper, Felix and Herbie (Felix and his twin Herbie pictured). They live in Altrincham near Manchester.

She studied Chemistry at the University of Hull and worked as a teacher and in the pharmaceutical industry. Lisa now runs the family property business in Manchester founded by her husband Karl.

They set up Team Felix in 2013, after their son Felix then 2, was diagnosed with Duchenne. The goal is to raise as much money as possible and as quickly as possible to fund research into treatments to end Duchenne.

Justine & Alex Latham

Justine and Alex’s third child, Jamie, was diagnosed with Duchenne muscular dystrophy just after his first birthday. At this time, Justine gave up her career as a stockbroker to become a full time mum. Alex has been in finance for nearly 20 years and in 2015, with the help of friends and family, Alex and Justine organised a triathlon, Tri4Duchenne which raised over £350,000 for Duchenne UK.

Divyesh Popat 

Divyesh joined IWG LLP, a firm of commercial lawyers based in Holborn in London in 1996 when he qualified as a solicitor, and has been a partner since the year 2000. He specialises in commercial litigation and dispute resolution. He is also father to Raul, an inspirational 13 year old boy with Duchenne muscular dystrophy. In 2007, soon after Raul was diagnosed, he became a trustee for Action Duchenne in order to support in every way possible those carrying out essential work to find treatments for Duchenne, and those working to improve the lives of the children living with the condition. While he has not been a trustee of Action Duchenne for a number of years, he (and IWG) have continued to support and work with Duchenne charities and the Duchenne community.

Vici Richardson

Vici has been involved in the Duchenne community for 12 years. She has a son Zak with Duchenne and two girls Eva and Sian.

Zak was diagnosed at 18 months old and since then Vici has campaigned and raised money for Duchenne research. She left her job in 2005 as a children's services manager for a childcare company and began work as PPUK's (now Action Duchenne) first fundraiser. She worked with them in lobbying parliaments in England Scotland,  Wales and Northern Ireland. 

For the last 6 years Vici has worked as a direct payment support officer with a disability charity and city council. Supporting people to use their social care budget  and giving information and advice in independent living. Vici is also a founder and trustee of Duchenne Now. 

Vici is committed to seeing a treatment for all in the shortest time frame possible. She is particularly keen to see non ambulant trials set up.